Annual EBITDA
-$109.04 M
-$57.12 M-110.03%
December 31, 2023
Summary
- As of February 7, 2025, PSTX annual EBITDA is -$109.04 million, with the most recent change of -$57.12 million (-110.03%) on December 31, 2023.
- During the last 3 years, PSTX annual EBITDA has risen by +$14.64 million (+11.84%).
Performance
PSTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
$23.89 M
+$51.66 M+186.06%
September 30, 2024
Summary
- As of February 7, 2025, PSTX quarterly EBITDA is $23.89 million, with the most recent change of +$51.66 million (+186.06%) on September 30, 2024.
- Over the past year, PSTX quarterly EBITDA has increased by +$51.66 million (+186.06%).
Performance
PSTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$46.16 M
+$51.88 M+52.92%
September 30, 2024
Summary
- As of February 7, 2025, PSTX TTM EBITDA is -$46.16 million, with the most recent change of +$51.88 million (+52.92%) on September 30, 2024.
- Over the past year, PSTX TTM EBITDA has increased by +$51.88 million (+52.92%).
Performance
PSTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PSTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -110.0% | +186.1% | +52.9% |
| 3 y3 years | +11.8% | +159.1% | +70.2% |
| 5 y5 years | -158.9% | +221.4% | +43.6% |
PSTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +110.0% | +7.4% | -67.6% | -333.4% | +201.5% | +195.6% |
| 5 y | 5-year | +110.0% | +13.4% | -67.6% | -333.4% | +201.5% | +235.4% |
| alltime | all time | +475.2% | +13.4% | -67.6% | -333.4% | +274.1% | +235.4% |
Poseida Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $23.89 M(-186.1%) | -$46.16 M(-52.9%) |
| Jun 2024 | - | -$27.76 M(+34.5%) | -$98.04 M(+4.1%) |
| Mar 2024 | - | -$20.64 M(-4.6%) | -$94.18 M(-13.6%) |
| Dec 2023 | -$109.04 M(+110.0%) | -$21.65 M(-22.7%) | -$109.04 M(-6.9%) |
| Sep 2023 | - | -$27.99 M(+17.1%) | -$117.09 M(+664.8%) |
| Jun 2023 | - | -$23.90 M(-32.7%) | -$15.31 M(-51.6%) |
| Mar 2023 | - | -$35.49 M(+19.5%) | -$31.64 M(-39.1%) |
| Dec 2022 | -$51.92 M(-55.7%) | -$29.70 M(-140.2%) | -$51.92 M(+177.2%) |
| Sep 2022 | - | $73.79 M(-283.4%) | -$18.73 M(-85.9%) |
| Jun 2022 | - | -$40.23 M(-27.9%) | -$132.93 M(-2.6%) |
| Mar 2022 | - | -$55.77 M(-1697.2%) | -$136.43 M(+16.5%) |
| Dec 2021 | -$117.06 M | $3.49 M(-108.6%) | -$117.06 M(-24.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$40.42 M(-7.6%) | -$154.81 M(+5.1%) |
| Jun 2021 | - | -$43.73 M(+20.1%) | -$147.27 M(+11.0%) |
| Mar 2021 | - | -$36.40 M(+6.3%) | -$132.63 M(+7.2%) |
| Dec 2020 | -$123.68 M(+51.2%) | -$34.26 M(+4.2%) | -$123.68 M(+10.7%) |
| Sep 2020 | - | -$32.88 M(+13.0%) | -$111.73 M(+13.4%) |
| Jun 2020 | - | -$29.09 M(+6.0%) | -$98.53 M(+1.7%) |
| Mar 2020 | - | -$27.45 M(+23.1%) | -$96.90 M(+18.5%) |
| Dec 2019 | -$81.78 M(+94.2%) | -$22.31 M(+13.4%) | -$81.78 M(+37.5%) |
| Sep 2019 | - | -$19.67 M(-28.4%) | -$59.48 M(+49.4%) |
| Jun 2019 | - | -$27.46 M(+122.6%) | -$39.80 M(+222.6%) |
| Mar 2019 | - | -$12.34 M | -$12.34 M |
| Dec 2018 | -$42.12 M(+122.2%) | - | - |
| Dec 2017 | -$18.95 M | - | - |
FAQ
- What is Poseida Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Poseida Therapeutics?
- What is Poseida Therapeutics annual EBITDA year-on-year change?
- What is Poseida Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly EBITDA year-on-year change?
- What is Poseida Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Poseida Therapeutics?
- What is Poseida Therapeutics TTM EBITDA year-on-year change?
What is Poseida Therapeutics annual EBITDA?
The current annual EBITDA of PSTX is -$109.04 M
What is the all time high annual EBITDA for Poseida Therapeutics?
Poseida Therapeutics all-time high annual EBITDA is -$18.95 M
What is Poseida Therapeutics annual EBITDA year-on-year change?
Over the past year, PSTX annual EBITDA has changed by -$57.12 M (-110.03%)
What is Poseida Therapeutics quarterly EBITDA?
The current quarterly EBITDA of PSTX is $23.89 M
What is the all time high quarterly EBITDA for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly EBITDA is $73.79 M
What is Poseida Therapeutics quarterly EBITDA year-on-year change?
Over the past year, PSTX quarterly EBITDA has changed by +$51.66 M (+186.06%)
What is Poseida Therapeutics TTM EBITDA?
The current TTM EBITDA of PSTX is -$46.16 M
What is the all time high TTM EBITDA for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM EBITDA is -$12.34 M
What is Poseida Therapeutics TTM EBITDA year-on-year change?
Over the past year, PSTX TTM EBITDA has changed by +$51.88 M (+52.92%)